Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Gonzalez-Angulo

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 18, 2011
Importance of accurate HER2 testing in patients with metastatic breast cancerAna Maria Gonzalez-Angulo
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
The importance of accuracy in HER2 testingAna Maria Gonzalez-Angulo
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the PI3K signaling pathway in cancer therapyChandra Bartholomeusz, Ana Maria Gonzalez-Angulo
Ochsner Journal|July 24, 2012
The role of chemotherapy in colon cancerAna Maria Gonzalez-Angulo, Jyotsna Fuloria
Clinical Advances in Hematology & Oncology : H&O|December 22, 2009
HER2-neu positivity in patients with small and node-negative breast cancer (pT1a,b,N0,M0): a high risk group?Mariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
Expert Opinion on Investigational Drugs|September 22, 2012
Everolimus in the treatment of hormone receptor-positive breast cancerMariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
The Oncologist|March 26, 2014
Implications of functional proteomics in breast cancerYoung Kwang Chae, Ana Maria Gonzalez-Angulo
Cancer Genomics & Proteomics|September 20, 2012
Breast cancer and metastasis: on the way toward individualized therapyAdriana Priscila Trapé, Ana Maria Gonzalez-Angulo
Nature Reviews. Clinical Oncology|January 9, 2013
Breast cancer in 2012: New drugs, new knowledge, new targetsMariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
Current Treatment Options in Oncology|December 11, 2013
Advances and future directions in the targeting of HER2-positive breast cancer: implications for the futureIshwaria M Subbiah, Ana Maria Gonzalez-Angulo
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinical Advances in Hematology & Oncology : H&O|February 18, 2011
Importance of accurate HER2 testing in patients with metastatic breast cancerAna Maria Gonzalez-Angulo
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
The importance of accuracy in HER2 testingAna Maria Gonzalez-Angulo
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the PI3K signaling pathway in cancer therapyChandra Bartholomeusz, Ana Maria Gonzalez-Angulo
Ochsner Journal|July 24, 2012
The role of chemotherapy in colon cancerAna Maria Gonzalez-Angulo, Jyotsna Fuloria
Clinical Advances in Hematology & Oncology : H&O|December 22, 2009
HER2-neu positivity in patients with small and node-negative breast cancer (pT1a,b,N0,M0): a high risk group?Mariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
Expert Opinion on Investigational Drugs|September 22, 2012
Everolimus in the treatment of hormone receptor-positive breast cancerMariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
The Oncologist|March 26, 2014
Implications of functional proteomics in breast cancerYoung Kwang Chae, Ana Maria Gonzalez-Angulo
Cancer Genomics & Proteomics|September 20, 2012
Breast cancer and metastasis: on the way toward individualized therapyAdriana Priscila Trapé, Ana Maria Gonzalez-Angulo
Nature Reviews. Clinical Oncology|January 9, 2013
Breast cancer in 2012: New drugs, new knowledge, new targetsMariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
Current Treatment Options in Oncology|December 11, 2013
Advances and future directions in the targeting of HER2-positive breast cancer: implications for the futureIshwaria M Subbiah, Ana Maria Gonzalez-Angulo
Pageof 8